Unanswered Concerns Of BVD-523 Revealed

Finch recommended that the research councils, together with other public sector bodies, OPHN1 should establish more effective and flexible arrangements to meet the cost of publishing in open access and hybrid journals. As a response, Research Councils UK (RCUK) has reviewed and revised its policy and, from April 1, 2013, new guidance comes into force. The latest revision, released on March 6, supports both ��gold�� open access (journal mediated, with authors retaining copyright under a CC-BY creative commons license after paying an article processing charge) providing immediate access, and ��green�� open access (repository mediated, with authors posting the final accepted version of their paper without restriction of use) after an embargo period of 6 months for biomedical research.2 The Lancet journals welcome and support all efforts to make research more widely accessible and useable in ways that continue to sustain our broad mission to serve clinical medicine and global health. We will, in accordance with the new RCUK policy, offer either a ��gold�� open access choice with a creative selleck compound commons license after payment of an article processing charge of US$5000, or a ��green�� open access solution��where authors can deposit the final accepted version of their paper in any repository they choose 6 months after publication��for all RCUK-funded research papers submitted after April 1. In addition, for the ��green�� open access solution we will also make the published paper free to access on our websites 6 months after publication. These options BVD-523 cell line and a choice of three different creative commons licenses (CC-BY, CC BY-NC-SA, or CC BY-NC-ND) will be open to authors of all research papers supported by those funders with whom we currently have payment agreements. Clearly, the debate on open access to publicly funded research is evolving and RCUK states that it ��will undertake a comprehensive, evidence-based review of the effectiveness and impact of its Open Access policy in 2014��. Given the rapid pace of discussions on open access publication, the Lancet journals will continue to review how we can make all publicly funded research as accessible and useable as possible. ""Associated Press Director-General of WHO from 1988 to 1998. Born in Chiba, Japan, on May 16, 1928, he died in Poitiers, France, on Jan 26, 2013, aged 84 years. Some 15 years ago, Sir George Alleyne was asked for his opinion of Hiroshi Nakajima's time as Director-General of WHO. It was 1998, the year Nakajima stepped down after 10 years of leadership that had been plagued by political tension and accusations of poor management.